Pulmonology

Uzm. Dr. Demet Polat Yuluğ

Doctor and researcher Mersin Şehir Hastanesi Mersin
AsthmaCystic FibrosisCOVID-19ObesityPseudomonas InfectionsEosinophilia
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Asthma 9 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Cystic Fibrosis 4 publications
  • COVID-19 3 publications
  • Obesity 3 publications
  • Pseudomonas Infections 2 publications
  • Eosinophilia 2 publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyPulmonologysaglik.gov.trFrom source
  • InstitutionMersin Şehir Hastanesisaglik.gov.trFrom source
  • Area of workAsthmaExtracted from 9 publications · Model version —From source
  • Publications59 publicationsOpenAlex, ORCIDFrom source
  • ORCID0000-0002-8122-4457ORCIDFrom source
  • Last synchronised5 November 2026 09:36https://mersinsehir.saglik.gov.tr/TR-638959/doktorlarimiz.html#demet-polat-yulugsaglik.gov.tr

Scientific work

Publications on Asthma

59 publications

  1. Determination of the yearly distribution of the incidence of Allergic Bronchopulmonary Aspergillosis (ABPA) in patients registered in the cystic fibrosis patient registry system of Turkey and identification of risk factors for its development

    Chronic Illness, 2026

    DOI 10.1177/17423953261452631 PMID 42216671 Open-access full textSource: OpenAlex

  2. Impact of CFTR modulators on respiratory support requirements and lung transplant candidacy status in advanced cystic fibrosis lung disease: data from the cystic fibrosis registry of Turkey

    Journal of Cystic Fibrosis, 2026

    DOI 10.1016/s1569-1993(26)00552-7 Source: OpenAlex

  3. Multidrug-Resistant and Difficult-to-Treat Pseudomonas aeruginosa in Cystic Fibrosis: A Nationwide Registry Analysis from Türkiye

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa3943 Source: OpenAlex

  4. Validation and Reliability Assessment of the Test of Adherence to Inhalers (TAI) in Turkish Patients with Chronic Obstructive Pulmonary Disease (COPD)

    Thoracic research and practice, 2026

    DOI 10.4274/thoracrespract.2026.2026-1-5 PMID 41979103 Open-access full textSource: OpenAlex

  5. Inhaler-specific drug therapy problems in COPD

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa2577 Source: OpenAlex

  6. Polypharmacy in COPD and Its Impact on Clinical Outcomes

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa5825 Source: OpenAlex

  7. An analysis of cystic fibrosis transmembrane conductance regulator gene variants in the Cystic Fibrosis Registry of Türkiye

    European Journal of Pediatrics, 2026

    DOI 10.1007/s00431-026-07498-x PMID 42963477 Source: OpenAlex

  8. Frailty, organ dysfunction and mortality in older ICU patients

    Scientific Reports, 2026

    DOI 10.1038/s41598-026-68534-2 Open-access full textSource: ORCID

  9. The Role of Genetic Testing in Rare Interstitial Lung Diseases: TRILD Registry Results

    European Respiratory Journal, 2026

    DOI 10.1183/13993003.congress-2026.pa3087 Source: OpenAlex

  10. Methylprednisolone in the management of post-COVID-19 interstitial lung disease: A randomized trial (STERCOV-ILD).

    Sarcoidosis vasculitis and diffuse lung diseases, 2026

    DOI 10.36141/svdld.2026.17022 PMID 41891406 Open-access full textSource: OpenAlex

View all 59 publications